Zincoderm M Cream is a topical formulation combining Clobetasol propionate (0.05% w/w), a potent corticosteroid, with Miconazole nitrate (2% w/w), an antifungal agent. This combination is indicated for the treatment of inflammatory dermatoses complicated by fungal infections, such as tinea corporis, tinea cruris, and other superficial mycoses with associated inflammation and pruritus. Clobetasol propionate exerts strong anti-inflammatory, antipruritic, and vasoconstrictive effects by modulating the release of inflammatory mediators and suppressing immune responses in the skin. Miconazole nitrate acts by inhibiting ergosterol synthesis, disrupting fungal cell membrane integrity, thereby exerting broad-spectrum antifungal activity against dermatophytes, yeasts, and molds. Zincoderm M Cream is intended for topical application on affected areas, typically twice daily or as directed by a healthcare professional. It is essential to use the cream for the prescribed duration to prevent recurrence and resistance. Caution is advised in prolonged use due to potential corticosteroid-related adverse effects such as skin atrophy, telangiectasia, and hypothalamic-pituitary-adrenal axis suppression. The product is contraindicated in viral infections, hypersensitivity to components, and should be avoided in pediatric patients unless specifically recommended. Zincoderm M Cream offers an effective therapeutic option for managing inflammatory fungal skin conditions requiring combined anti-inflammatory and antifungal treatment.